Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Morgan Roupret, MD, PhD, from the Pitié-Salpétrière Hospital, Paris, France, discusses management of side effects in treatment of bladder cancer at the European Association of Urology (EAU) conference 2017 in London, UK. He states that in the near future, medication delivered directly to the bladder will be available to reduce the side effects of BCG and chemotherapy.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.